Oxcia AB is developing a first-in-class oncology lead candidate in two ongoing phase I trials and a novel therapy to inhibit inflammation and fibrosis
Company Details
- Employees
- 12
- Founded
- -
- Address
- Norrbackagatan 70c, Stockholm,sweden
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://oxcia.com
- Keywords
- Oxcia’s innovative science.
- HQ
- Stockholm
Oxcia Ab (Publ) Questions
Oxcia Ab (Publ)'s website is https://oxcia.com
Oxcia Ab (Publ)'s LinkedIn profile is https://se.linkedin.com/company/oxcia-ab
Oxcia Ab (Publ) has
12 employees.
View email and phone details for 12
employees at Oxcia Ab (Publ).
Oxcia Ab (Publ)'s industry is
Pharmaceutical Manufacturing
Oxcia Ab (Publ)'s top competitors are
Synact Pharma,
One-Carbon Therapeutics Ab,
Ectin Research,
Oxeia Biopharmaceuticals Inc,
Curacell,
Scendea,
Oncopeptides Ab (Publ),
Smartcella Holding Ab,
Monte Rosa Partners,
Bionordika Sweden Ab.
Oxcia Ab (Publ)'s categories are Pharmaceutical Manufacturing
Oxcia Ab (Publ)'s founding year is 2014
